These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30078158)

  • 1. Novel Therapies in Acute Lymphoblastic Leukemia.
    Phelan KW; Advani AS
    Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed/refractory acute lymphoblastic leukemia.
    Paul S; Rausch CR; Nasnas PE; Kantarjian H; Jabbour EJ
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):166-175. PubMed ID: 30969955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors.
    Advani AS
    Hematology Am Soc Hematol Educ Program; 2013; 2013():131-7. PubMed ID: 24319174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia.
    Advani A
    Best Pract Res Clin Haematol; 2015; 28(2-3):116-23. PubMed ID: 26590768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of acute lymphoblastic leukemia.
    Rafei H; Kantarjian HM; Jabbour EJ
    Leuk Lymphoma; 2019 Nov; 60(11):2606-2621. PubMed ID: 31092071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
    Kebriaei P; Poon ML
    Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.
    O'Dwyer KM; Liesveld JL
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in pediatric B-cell acute lymphoblastic leukemia.
    Wyatt KD; Bram RJ
    Hum Immunol; 2019 Jun; 80(6):400-408. PubMed ID: 30716352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Acute Lymphoblastic Leukemia.
    Rheingold SR
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469898
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
    Hochberg J; El-Mallawany NK; Cairo MS
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
    Tomuleasa C; Fuji S; Berce C; Onaciu A; Chira S; Petrushev B; Micu WT; Moisoiu V; Osan C; Constantinescu C; Pasca S; Jurj A; Pop L; Berindan-Neagoe I; Dima D; Kitano S
    Front Immunol; 2018; 9():239. PubMed ID: 29515572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia.
    DeAngelo DJ
    Hematology Am Soc Hematol Educ Program; 2015; 2015():400-5. PubMed ID: 26637749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-engaging therapies - BiTEs and beyond.
    Goebeler ME; Bargou RC
    Nat Rev Clin Oncol; 2020 Jul; 17(7):418-434. PubMed ID: 32242094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia.
    Gavralidis A; Brunner AM
    Curr Hematol Malig Rep; 2020 Aug; 15(4):294-304. PubMed ID: 32445026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.
    Aldoss I; Bargou RC; Nagorsen D; Friberg GR; Baeuerle PA; Forman SJ
    Leukemia; 2017 Apr; 31(4):777-787. PubMed ID: 28028314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
    Sikaria S; Aldoss I; Akhtari M
    Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Treatment Options for Acute Lymphoblastic Leukemia: Focus on CAR T-Cell Therapy.
    Brown PA; Shah B
    J Natl Compr Canc Netw; 2018 May; 16(5S):651-655. PubMed ID: 29784748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia.
    Barsan V; Ramakrishna S; Davis KL
    Curr Oncol Rep; 2020 Jan; 22(2):11. PubMed ID: 31997022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunotherapies in lymphoid malignancies.
    Batlevi CL; Matsuki E; Brentjens RJ; Younes A
    Nat Rev Clin Oncol; 2016 Jan; 13(1):25-40. PubMed ID: 26525683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
    Singh N; Frey NV; Grupp SA; Maude SL
    Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.